4.3 Article

Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial

Zhihong Liu et al.

ANNALS OF INTERNAL MEDICINE (2015)

Article Urology & Nephrology

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Urology & Nephrology

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

Howard A. Austin et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Urology & Nephrology

Successful treatment of class V+IV lupus nephritis with multitarget therapy

Hao Bao et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Review Rheumatology

Therapeutic options for resistant lupus nephritis

Chi Chiu Mok

SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)

Article Urology & Nephrology

The classification of glomerulonephritis in systemic lupus erythematosus revisited

JJ Weening et al.

KIDNEY INTERNATIONAL (2004)

Article Public, Environmental & Occupational Health

Estimating the relative risk in cohort studies and clinical trials of common outcomes

LA McNutt et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)

Article Medicine, General & Internal

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis

TM Chan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)